The activity of a new i.v. anaesthetic agent ICI 35 $68, a compound unrelated to currently used barbiturate, eugenol or steroid agents, has been examined in a range of animal species. Some of the properties of ICI 35 868 resemble those of thiopentone in that it is a rapidly acting agent which produces anaesthesia of short duration and without excitatory side-effects. Both agents have a similar therapeutic index and produce equivalent cardiovascular and respiratory effects. In the mouse ICI 35 868 is 1.8 times more potent than thiopentone as a hypnotic. However, the anaesthetic profile of ICI 35 868 differs from that of thiopentone in that recovery is rapid following repeated administration, no tissue damage is produced by perivascular or intra-arterial injection and greater reflex depression and more profound e.e.g. changes are produced at equipotent doses. This new agent has been shown to be compatible with a wide range of drugs used for prcanaesthetic medication, inhalation anaesthetics, and neuromuscular blocking drugs.
Although sodium thiopentone is widely used for induction of anaesthesia, delay in recovery which is associated with repeated administration precludes its use for the maintenance of hypnosis during prolonged operations.
The more recently introduced i.v. anaesthetics are more rapidly metabolized, and hence more controllable, than thiopentone, but have failed to reproduce fully the quality of anaesthesia provided by thiopentone. I.v. anaesthesia utilizing an infusion of Althesin has been described by Savege and others (1975) . This technique had the advantage of eliminating anaesthetic gases and vapours from the theatre environment, but did not always provide smooth easily-controlled anaesthesia, the principal complication found being movement.
Anaesthetic activity has been discovered in a series of hindered phenolic compounds which exist as oils at room temperature. These compounds can be administered i.v. in aqueous solution with the solubilizing agent Cremophor EL. Animal tests were designed to detect a compound which produced anaesthesia characterized by rapid onset, short duration, lack of cumulation on repeated administration, and a lack of excitatory effects on induction and during maintenance and recovery. Of the compounds examined only ICI 35 868 was found to have a desirable anaesthetic profile in animals.
The pharmacological effects of this compound are such that it is being developed as an agent suitable both for induction and maintenance of anaesthesia in man and animals. This paper describes the results of some experiments designed to evaluate the properties of ICI 35 868 in animals and to compare its activity with that of a range of currently used i.v. anaesthetics.
MATERIALS
The active agent in ICI 35 868 is 2,6-diisopropylphenol ( fig. 1 ), a chemical entity unrelated to any of the currently used barbiturate, eugenol, or steroid anaesthetic agents. The compound has low solubility in water at ambient temperatures, but aqueous solutions can be prepared using solubilizing agents such as Cremophor EL (polyoxyethylated castor oil, BASF) and other similar surfactants.
Single dose studies in rabbits and cats were carried out with ICI 35 868 administered as a 2% formulation in 10% Cremophor EL. In all the other studies suitable doses were prepared from a clinical trial formulation containing 2% ICI 35 868 in 16% Cremophor and 8.66% ethyl alcohol (all % w/v) . In all species except mice the clinical trial formulation was used in undiluted form. For experiments in mice the clinical trial formulation was diluted with distilled water to obtain preparations containing 1% and 0.5% ICI 35 868. In a later clinical trial formulation the active drug concentration was reduced to 1% and ethyl alcohol was omitted. No significant difference in anaesthetic activity has been produced in animals by the removal of ethyl alcohol from the formulation or by varying the amount of Cremophor EL in the formulation between 5% and 20%.
The mixture of anaesthetic steroids containing alphaxalone 9 mg and alphadolone acetate 3 mg per millilitre, which was used in some comparative studies, is described by the trade name Althesin (Glaxo) and doses refer to the total steroid content of the mixture, 12 mg ml" 1 in the commercial preparation.
METHODS AND RESULTS

Anaesthetic activity: single dose studies
The anaesthetic activity of ICI 35 868 has been investigated in mice, rats, rabbits, cats, pigs and monkeys. Inj ections were made into the tail veins of mice and rats, the ear veins of rabbits and pigs, the cephalic vein in cats and the saphenous vein in monkeys. All injections were given over 10 s to mice and rats. In the larger species administration rates of 0.25-0.5 mg kg" 1 s" 1 were used. Groups of 10 male Alderley Park mice (18-24 g body weight) were used at each dose tested. During the period of sleep mice were maintained at an ambient temperature of 35 °C. The dose required to abolish righting reflexes for a minimum period of 30 s in 50% of mice (the median hypnotic dose, HDj,,) and the dose producing a lethal effect in 50% of mice (LD W ) were estimated by fitting parallel logit lines derived from the dose-response results.
The results obtained with ICI 35 868 and some other i.v. anaesthetics are given in table I. The activity of ICI 35 868 in mice was found to lie between that of thiopentone and methohexitone, being closer to the latter. No significant differences in the values for HDjo, LD M and therapeutic index were obtained when the activity of ICI 35 868 was examined in both male and female mice.
Using a technique described previously (Glen, 1977a ) the speed of onset of effect of ICI 35 868 was compared with that obtained with some other anaesthetic agents. Values for HD W were determined using both a standard 10-s injection rate and a rapid (1-s) injection. Induction times were then noted 1 was given and effects compared with those of thiopentone, methohexitone, and Althesin at doses equivalent to 2 x HD W for these agents. Respiratory rates were counted with the aid of a low pressure transducer (Bradshaw, Biswas and Pleuvry, 1973) 1 min after induction of anaesthesia. Reflex depression was assessed with an artery clip applied to the tail and toes, and co-ordination was tested with a metal rod walking test. Mice were classed as coordinated when, on being placed on the rod, they either maintained their balance for 20 s or walked to the end of the rod within a shorter period. The duration of loss of righting reflex was noted and also the time required after righting before mice walked from the centre to the periphery of a 30-cm diametec disc.
The results given in tables III and IV show that mean sleeping time with ICI 35 868 was similar to that obtained with thiopentone and slightly longer than that found with Althesin and methohexitone. Recovery of walking ability returned after a similar period with all the drugs, but the slight difference between ICI 35 868 and the barbiturates was statistically significant. Following ICI 35 868, methohexitone and Althesin, mice regained co-ordination rapidly, whereas about 40 min elapsed before those mice given thiopentone had recovered completely. Respiratory rates obtained with thiopentone and ICI 35 868 were less than those found with methohexitone and Althesin, but only in the comparison with Althesin was this difference statistically significant.
A short period of 5-10 s of apnoea followed injection of ICI 35 868. This period of apnoea was not seen if a slower rate of injection was used. The degree of reflex depression associated with ICI 35 868 was greater than that seen, with the other agents investigated. Recovery from the effects of ICI 35 868 and thiopentone was tranquil, whereas mice recovering from methohexitone and Althesin showed some muscle tremor and twitching, particularly when being handled in the co-ordination test.
Estimates of HD^, LD M and therapeutic index were also made in rats using the technique already described for mice. Groups of 10 male rats (170-220 g) were used at each dose tested. In rats ICI 35 868 was With doses of 5 mg kg" 1 and 10 mg kg" 1 relaxation occurred 10-15 s after the end of injection, whereas greater doses induced anaesthesia immediately. With doses of 25 mg kg" 1 and more, respiration was initially slow and shallow and cyanosis was noted. Muscle relaxation was good at all doses except the smallest where some tone persisted in rats which did not lose righting reflexes.
Dose-response effects produced by ICI 35 868 in the rabbit, cat, pig and monkey are shown in histogram form in figure 2. Anaesthesia was of very short duration in the rabbit and little reflex depression was obtained. In the other species, responses to painful stimuli were abolished with the larger doses used and the duration of anaesthesia increased. Induction and recovery were free from excitatory side-effects and good muscle relaxation was produced at all anaesthetic doses. A short period of apnoea occurred frequently in rabbits, cats and pigs following administration of the greater doses of ICI 35 868. In monkeys apnoea was seen only on one occasion, following a dose of 15 mg kg-1 . In two pigs the duration of apnoea following doses of 7.5 mg kg" 1 was sufficient to warrant a short period of artificial ventilation. In these studies ICI 35 868 was administered on a total of 92 occasions. A lethal effect was obtained in six rabbits and one cat given a dose of 20 mg kg" 1 when respiratory arrest occurred and no attempt was made to provide artificial ventilation. No sign of any delayed toxic effect was seen in the remaining animals which all recovered rapidly and were alert and keen to eat shortly after regaining the ability to walk.
Perivenous and intra-arterial administration
No vein damage occurred in any nnimni and no tissue necrosis followed the intentional perivascular injection of the 1 % formulation of ICI 35 868 in 16% Cremophor EL in the mid-tail region of mice. This formulation also failed to produce any damage when given directly into the central ear artery in rabbits using the technique of Kinmonth and Shepherd (1959) . In both of these circumstances thiopentone sodium 5% produced macroscopically obvious tissue necrosis.
I.m. administration
In rabbits ICI 35 868 60 mg kg-1 produced only moderate sedation after 12 min, suggesting that rapid metabolic breakdown or clearance of the agent in this species prevents the attainment of anaesthetic blood concentrations.
In one cat given ICI 35 868 20 mg kg-1 i.m., marked ataxia was produced after 12 min. A second cat given 36 mg kg" 1 became increasingly sedated until righting reflexes were lost at 18 min after injection. Good relaxed anaesthesia then ensued for a further 1 h, but this large dose requirement was associated with a slow recovery.
E.e.g. effects
The e.e.g. effects of ICI 35 868 were investigated in 200-g male rats with previously implanted jugular venous cannulae and gold-plated cortical electrodes. Bipolar recordings were obtained from bilateral parietal electrodes. The e.e. rapidly acting barbiturates in this species. One difference noted was that burst suppression was produced at a dose dose to the median hypnotic dose whereas the barbiturates only produced burst suppression when doses in excess of 2 x HD^, were given.
Intermittent injection and infusion studies
Anaesthesia has been maintained by repeated injection or continuous infusion of ICI 35 868 in mice, rabbits, rats, cats and pigs. The rate of "utilization" of the compound in these species has been calculated by dividing the total dose administered by the duration of anaesthesia from induction to headlift. Summary results are given in table VI. Species 
Haemodynamic and respiratory effects
Experiments were performed in Large White and Landrace pigs (17-40 kg) in which polythene arterial and venous cannulae had previously been implanted. The effects of ICI 35 868 were compared with those of equivalent doses of thiopentone and Althesin. All doses were given in a standard injection time of 30 s. Arterial pressure was measured with a strain-gauge transducer, heart rate was derived electronically from the arterial pressure record and arterial Po v \Pco t and pH were measured with standard Radiometer electrodes.
The effects on mean arterial pressure and heart rate are shown in tables VIII and IX. All three agents produced an initial hypotensive effect which was significant 1 min after injection. The hypotensive effect was accompanied by tachycardia which was most marked in animals given thiopentone and Althesin.
The results of blood-gas analyses are given in table X. All three agents investigated produced minimal changes in the variables measured.
Injection of Cremophor EL, in volumes equivalent to those used in the preparation of ICI 35 868 and Althesin, produced no detectable changes in arterial pressure or breathing.
The effect of ICI 35 868 and other i.v. agents on peripheral vasculature was investigated in two cats anaesthetized with chloralosc 60 mg kg" 1 i.v. Pressures were measured in a systemic artery and in an isolated perfused hind limb and acute effects of the anaesthetics on these variables were compared with those of the a-adrenergic blocking agent, phentolamine. In common with thiopentone and Althesin, ICI 35 868 produced dose-related reductions in pressure in an isolated perfused hind limb. This result indicates that at least a portion of the hypo- tensive effect of these agents is the result of a decrease in peripheral vascular resistance.
Effect on broncfwmotor tone
Airway pressure was monitored in three pigs during constant volume positive pressure ventilation with a Palmer pump. Pigs weighing 24-28 kg were anaesthetized with pentobarbitone and the trachea was intubated with a cuffed tube. ICI 35 868 0.5-4.0 mg kg" 1 produced no effect on airway pressure. Subsequent administration of histamine 1-4 y.g kg" 1 produced detectable increases in airway pressure, an 
Cardiovascular reactivity
Cardiovascular responses to adrenaline, noradrenaline and acetylcholine were measured in conscious pigs and during anaesthesia maintained with an infusion of ICI 35 868.
The pressor response and reflex bradycardia obtained with both adrenaline and noradrenaline was greater in anaesthetized pigs, whereas the responses to acetylcholine were quantitatively very similar in both conditions. The increased pressor responses obtained with adrenaline and noradrenaline are partly explained by smaller pre-dose values in the anaesthetized state as the mayimnm values reached were similar in conscious and anaesthetized animals. No ventricular arrythmia was produced by the administration of adrenaline
Effects of overdosage
Two experiments were conducted in cats to investigate the haemodynamic and respiratory effects of progressively increasing doses of ICI 35 868. Cats were allowed to recover to a light level-of anaesthesia before a further dose of anaesthetic was given. In one cat artificial ventilation of the lungs was provided to counter the respiratory effects of large doses of ICI 35 868.
Anaesthesia was induced with ICI 35 868 10 mg kg" 1 and preparations made to record arterial pressure, central venous pressure, Lead II electrocardiogram, heart rate and respiratory rate. The return of swallowing reflexes was the sign taken for the administration of a further dose of anaesthetic. For the first 1 h anaesthesia was maintained with minimal supplementary doses of ICI 35 868. This dose was found to be 2.5 mg kg" 1 , administered at about 10-min intervals. The doses given subsequent to this period were gradually increased until a lethal effect was obtained.
No significant change in any of the indices was produced with doses less than lOmgkg"
1 . With doses of 10 mg kg" 1 or more there was a period of apuoea and dose-related hypotension. When artificial ventilation was not used, the initial hypotensive effect was followed by a marked pressor effect, during the apnoea produced by doses of 15 mg kg" 1 and 20 mg kg"
1 . When spontaneous ventilation returned arterial pressure decreased again and then gradually returned to the pre-dose value over a period of 10 min. Heart rate decreased and central venous pressure increased during the initial hypotensive phase, indicating a negative inotropic effect of the drug at these large doses. In the cat where apnoea was prevented by artificial ventilation, large doses produced a hypotensive effect without any subsequent hypertensive response.
These experiments demonstrated that large doses of ICI 35 868 produce both respiratory and cardiovascular depression. With a dose of 20 mg kg" 1 these effects combined to produce a lethal outcome when ventilation was not supported. With controlled ventilation one cat survived a dose of 30 mg kg" 1 despite severe hypotension for a period. In this cat the degree of hypotension did not increase with increasing doses greater than 20 mg kg" 1 .
Local anaesthetic effects
No surface anaesthesia was produced by the application of a 2% solution of ICI 35 868 to the rabbit cornea using the technique of Bulbring and Wajda (1945) .
Interactions with drugs used in pre-anaesthetic medication
A selection of ataractic, sedative, antichoUnergic and analgesic drugs was administered s.c. to mice 30 min before induction of anaesthesia with an i.v. injection of ICI 35 868 25 mg kg"
1 . The drugs and doses given were: droperidol 0.25 mgkg" 1 ; chlorpromazine hydrochloride 1.0 mg kg" 1 ; promethazine hydrochloride 2.5 mgkg" 1 ; diazepam 2.0 mg kg" 1 ; atropine sulphate 1.0 mg kg" 1 ; hyoscine hydrobromide 1.0 mg kg" 1 ; pethidine hydrochloride 1.0mgkg" 1 ; papaveretum 2.5 mg kg" 1 ; pentazocine hydrochloride 10.0 mg kg" 1 ; pentobarbitone sodium 10.0mgkg" 1 ; quinalbarbitone sodium 10.0mgkg" 1 ; amylobarbitone sodium 10.0 mg kg" 1 and 40 mg kg" 1 .
A significant increase in sleeping time occurred following premedication with chlorpromazine, diazepam, papaveretum and the greater dose of amylobarbitone. A number of drugs including diazepam and droperidol caused delay in the recovery of walking ability and co-ordination, and a short but statistically significant delay in recovery was noted following atropine or hyoscine pre-medication. Pentazocine and amylobarbitone 40mgkg"" 1 caused a significant slowing of respiratory frequency and papaveretum increased the duration of apnoea seen at induction. Following premedication with atropine and hyoscine there was no apnoea.
Further experiments showed that the magnitude of the potentiating effects of the preanaesthetic drugs on the action of ICI 35 868 was similar to that seen with Althesin. The combination of diazepam, droperidol or chlorpromazine with thiopentone produced much greater increases in sleeping times. The results of these experiments will be reported in more detail elsewhere.
Interactions with inhalation anaesthetics
Three adult cats (1.8-2.3 kg) were anaesthetized with each combination examined. Each cat was given an induction dose of ICI 35 868 7.5 mg kg" 1 and the trachea was intubated following the application, in aerosol form, of lignocaine 10 mg to the laryngeal mucosa. The inspired concentration of each inhalation agent investigated was adjusted to maintain a light level of anaesthesia, the lower concentrations used being those required for maintenance of anaesthesia in this species. All agents, with the exception of cyclopropane were delivered to the cats via an Ayre's T-piece with fresh gas flows ranging from 1.5 to 4 litre min"
1 . Cyclopropane mixtures, prepared in nylon reservoir bags, were administered through a unidirectional valve.
A summary of the main findings with each agent is given in table XI. Anaesthesia was maintained satisfactorily with all the-inhalation agents tested and no unexpected interactions were observed. The responses of the cats during maintenance reflected the pharmacological properties of the inhalation agents employed.
Interactions with neuromusadar blocking drugs
Adult cats were used to investigate any possible interactions between ICI 35 868 and suxamethonium, gallamine and pancuronium. Pre-anaesthetic medication was restricted to atropine sulphate 0.2 mg administered i.m. 30 min before an induction dose of ICI 35 868 7.5 mg kg"
1 . Anaesthesia was maintained with 0.5-2% halothane delivered via an Ayre's T-piece system. On a number of occasions the neuromuscular blocking drugs were antagonized with neostigmine and in some animals the nondepolarizing drugs were administered when recovery of spontaneous respiration had occurred following the administration of suxamethonium.
A summary of the experimental details and resluts is given in table XII. All the animals used in these experiments recovered uneventfully and no unexpected interactions were observed which could be related to the combination of ICI 35 868 with any of the neuromuscular blocking drugs investigated. Limb movements noted in one cat at the time of injection of pancuronium were attributed to the fact that the level of anaesthesia at that time was insufficient to prevent spontaneous movement when the animal was disturbed in the process of giving the injection. Because of the histamine-releasing properties of tubocurarine in the cat, the effects of this relaxant were investigated in pigs (12-22 kg) anaesthetized with an induction dose of ICI 35 868 5 mg kg" 1 following premedication with atropine sulphate 0.3 mg and droperidol 2.5 mg. A Magill circuit was used during maintenance with 0.5-2% halothane in a total fresh gas flow of 6 litre min-1 of a 50 : 50 mixture of nitrous oxide and oxygen. Cuffed endotracheal tubes were used in pigs, suxamethonium being used to provide suitable conditions for intubation. Tubocurarine 0.15 mg kg" 1 was given when spontaneous respiration had returned and a stable depth of anaesthesia achieved. Residual relaxation was readily reversed with neostigmine 1.25 mg in two pigs. All the pigs used in this study recovered uneventfully and no unexpected interactions were encountered.
In mice tie combination of suxamethonium and propanidid causes a marked reduction in respiratory frequency, measured 2 min after injection of the mixture. The sleeping time produced by propanidid is also considerably extended (Glen, 1977b) . The combination of ICI 35 868 with suxamethonium did not cause effects similar to those seen with the propanidid combination.
DISCUSSION
In a range of animal species the anaesthetic properties of ICI 35 868 have been found to be similar to those of thiopentone. Single doses of both agents produced anaesthesia characterized by rapid onset, short duration and freedom from excitatory sideeffects, and both produced a degree of respiratory depression at larger doses. Hypotensive effects in pigs and therapeutic indices in mice were also similar. The hypnotic potency in mice of ICI 35 868 was 1.8 times greater than that of thiopentone. The anaesthetic profile of ICI 35 868 differed from that of thiopentone in that repeated doses could be given without significantly prolonging recovery time, complete recovery from a single dose occurred more rapidly, no tissue damage occurred following perivascular or intra-arterial injection and better reflex depression was obtained in mice at equipotent doses.
In this study a standard injection time was used in mice and a finite period of sleep specified in the calculation of HDg,, values. These factors probably account for the lower therapeutic indices obtained with standard agents (table I) in comparison with those found by Child and others (1971) . When a faster rate of injection was used in the assessment of speed of induction it was found that a much smaller dose of ICI 35 868 was required to cause the same effect. Although the other standard agents examined showed a similar change, only in the case of propanidid, another rapidly metabolized agent, did the magnitude of the effect approach that seen with ICI 35 868. This suggests that the dose requirement and speed of onset of anaesthesia in man with ICI 35 868 will be significantly affected by changes in the rate of injection. With a slow rate of administration, the effect of metabolism occurring during the course of an injection may limit the rate of increase in the blood concentration of the agent. Experiments in rats using whole-body autoradiographic techniques have demonstrated the presence of metabolic products of ICI 35 868 in the liver 30 s after i.v. injection (Rhodes and Longshaw, 1977) .
The e.e.g. changes produced by ICI 35 868 in the rat indicate that the compound can produce profound, but rapidly reversed, depression of cerebral activity at doses close to the median hypnotic dose. This suggests that the dose-response curve for the cerebral depressant effect of ICI 35 868 is likely to be steeper than that obtained with the barbiturates with the result that little hypnosis is likely to be seen as the blood concentration decreases to less than that required to produce unconsciousness.
The combination of ICI 35 868 with drugs used for pre-anaesthetic medication, inhalation agents, and neuromuscular blocking drugs did not demonstrate any unexpected interactions. The movement noted in one cat at the time of administration of pancuronium was attributed to an inadequate level of anaesthesia, but may have been a manifestation of an initial stimulating action of pancuronium similar to that which has been described in a proportion of cats on the first administration of tubocurarine or gallamine (Payne, 1961) .
Highly lipophilic compounds like ICI 35 868 were not previously examined in tests for anaesthetic activity because of their insolubility in aqueous solution. The availability of Cremophor EL as a solubilizing agent has removed this obstacle and has allowed the properties of ICI 35 868 to be examined in animals and in preliminary clinical investigations. An early study in man (Kay and Roily, 1977) concluded that ICI 35 868 appeared to be a clinically effective induction agent with pain after injection being the only side-effect seen. This side-effect had not been predicted from studies in animals.
Should further work in man confirm that ICI 35 868 has a desirable anaesthetic profile, it is hoped that an alternative formulation can be developed which would be more acceptable for wider clinical use. 
SUMARIO
Se ha examinado la actividad de un nuevo agente anestisico intravenoso, el ICI 35 868, en una gama de especies animates; este compuesto no esta relacionado con los agentes barbituricos, eugenol, ni esteroides actualmente en uso. Ciertas propiedades del ICI 35 868 se asemejan a las de la tiopentona, respecto a que es un agente de rapida acci6n que produce anestesia de corta duraci6n y sin efectos secundarios de excitaci6n. Ambos agentes poscen un indice terapeutico similar y producen efectos cardiovasculares y respiratorios equivalentes. En lo que respecta al rat6n, el ICI 35 868 es un hipn6tico 1,8 veces mis potente que la tiopentona. No obstante, la configuraci6n anestesica del ICI 35 868 difiere de la tiopentona en que su recuperaci6n es rapida despues de repetidas administraciones, no se produce dano alguno a los tejidos a causa de inyecciones perivasculares o intraarteriales y a igualdad de potencia de las dosis se produce una mayor depresi6n de reflejos y cambios electroencefalograficos mas profundos. Este nuevo agente ha demostrado ser compatible con una amplia gama de drogas usadas en medicacidn preanestesica, anestesicos de inhalaci6n y drogas de bloqueo neuromuscular.
